Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines. - Wikidata - awgldk - TriplyDB

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

http://www.wikidata.org/entity/Q34641349

about

Targeted therapy of gastrointestinal stromal tumours Plastic and Reconstructive Surgery in the Treatment of Oncological Perineal and Genital Defects Clinical practice guidelines for patients with gastrointestinal stromal tumor in Taiwan Management of early asymptomatic gastrointestinal stromal tumors of the stomach Developing an Evidence-based Followup Schedule for Bone Sarcomas Based on Local Recurrence and Metastatic Progression.Successful treatment of bleeding large duodenal gastrointestinal stromal tumour in a patient under dual antiplatelet therapy after recent drug-eluting coronary stent implantation Evaluation of high-risk clinicopathological indicators in gastrointestinal stromal tumors for prognosis and imatinib treatment outcome.Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology Minimally invasive surgery for submucosal (subepithelial) tumors of the stomach.Prediction of Tumor Recurrence in Patients with Non-Gastric Gastrointestinal Stromal Tumors Following Resection according to the Modified National Institutes of Health Criteria.A high risk group in the modified national institutes of health consensus criteria for the gastrointestinal stromal tumor: a clear indication of the adjuvant imatinib.External beam radiation therapy for locally advanced and metastatic gastrointestinal stromal tumors.Gastrointestinal stromal tumor: 15-years' experience in a single center TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)Prediction of desmoid tumor progression using miRNA expression profiling Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trials.Homogenous Good Outcome in a Heterogeneous Group of Tumors: An Institutional Series of Outcomes of Superficial Soft Tissue Sarcomas.Comparison of Endoscopic and Open Resection for Small Gastric Gastrointestinal Stromal Tumor Resection and Abdominal Wall Reconstruction of a Desmoid Tumor with Endometrioma Features.Oral administration of sunitinib malate for long-term survival of a patient with multiple lung metastases from renal leiomyosarcoma.Surgical resection should be taken into consideration for the treatment of small gastric gastrointestinal stromal tumors.A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion.Retrospective analysis of 85 cases of intermediate-risk gastrointestinal stromal tumor.Endoscopic versus laparoscopic resection of gastric gastrointestinal stromal tumors: a multicenter study.Novel pathways and molecular targets for the treatment of sarcoma.Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapy.The desmoid tumour: local control after surgical treatment.Gastrointestinal stromal tumors: who should get imatinib and for how long?Treatment Considerations for Cancer Pain: A Global Perspective.Desmoid: the role of local therapy in an era of systemic options.Diagnosis and surgical treatment of esophageal gastrointestinal stromal tumors.Effective Downsizing of a Large Oesophageal Gastrointestinal Stromal Tumour with Neoadjuvant Imatinib Enabling an Uncomplicated and without Tumour Rupture Laparoscopic-Assisted Ivor-Lewis Oesophagectomy.A rare combination between familial multiple lipomatosis and extragastrointestinal stromal tumor.Laparoscopic total gastrectomy for a giant gastrointestinal stromal tumor (GIST) with acute massive gastrointestinal bleeding: a case report.CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up.Fibromatosis of the Breast: Diagnostic Accuracy of Core Needle Biopsy.

P2860

Q26745633-589C2B22-A933-4F10-99E6-F39B960C3F81 Q26779116-14D72F08-9A09-4CCE-9920-2C08EE6DEBDF Q27027632-36F86105-CA0D-4B56-B5E0-4C726BF6D1FC Q30434738-D7C5099D-8D56-4134-8A4B-C52B9B7311BB Q33276119-D98EDB95-95DE-4181-85D2-DF416FF621DD Q33565542-0FD1B930-D192-4C53-9CFD-926C7E171E82 Q33756596-57E277AD-48D3-41A1-89D8-4CF7092F2595 Q34168680-B7DB3B04-B5FA-42B4-9BA3-8BA01C096B94 Q34255520-AE1A9BFB-496B-4803-9C0E-E74DC5445F52 Q34378739-0495D2B0-3882-4668-9C6C-039F451ED945 Q34378749-22617C09-92AD-4111-B7D2-0E65A45D7CCD Q34461532-D154BA53-1616-487A-887A-8286448E912E Q34623358-EFE599CE-F43A-4E79-BA2F-5DD64ADE9EAF Q34660470-AC403D72-2C3B-449B-98E4-9CAF29CC6F75 Q34664305-C53E2B68-A2C0-4878-A6FE-D27227DABE2A Q35674236-BAB0A88E-9E8C-4A1D-8D94-423F06EE77DC Q35915389-CC859F5E-BF96-4C38-8095-2F53C15CB94F Q36192000-976B0014-F9E3-4CE1-A05E-1302C118CEB8 Q36304626-7FDA7F10-45B3-468A-9A37-72629112957E Q36427502-BEEEEAAA-4379-4754-A163-3212D370279F Q36928171-946ACC90-0032-4230-A486-9B217B1CC4BA Q37152297-6AC0CD1C-11C2-4E5A-A84D-9E9B679B9C3E Q37365970-27D249A3-2B98-468A-A892-2C4206229E6E Q37417062-CC965AB0-340B-4560-8314-B705C7F88E9A Q37495285-65BCEAFE-3124-439C-B44A-B051606C17BD Q37705793-289875A1-CC8D-4E78-9456-908DE99A6517 Q37706898-3292AD47-EB54-446B-9362-734CEFF77977 Q38105496-029A627A-23A5-41FA-B5E6-D068411750A9 Q38112821-47ACEB7C-7D40-4A1C-BD9C-150BE4AEEB3D Q38239332-993B0E5E-1CB2-46D8-A311-0C4AA38BE149 Q38257940-687D60BE-5E12-4706-9639-0241B2BD1F14 Q38282157-211BB5DB-BDF3-4712-B798-3FAB8194BB3C Q39403331-F5429B45-E7AD-4D6B-A5AB-CAA3B9BD0DE4 Q40545711-B7548CE3-B33F-47E4-A872-62B7BC78508F Q40812894-834C3EEF-7213-469B-881D-58B457915381 Q43247509-0042D008-5FFF-4151-A15C-24FA1C559D14 Q47102134-94798A3F-B468-4CA1-9086-27B000FFC0D8 Q47862484-3F53E467-0241-452A-BCB8-322E8053980E Q47891687-03EC02C2-BDFC-4705-ABC4-57179D38B74D Q47934656-825A4CF1-0DA1-4026-B147-48EB7F31D2B7

P2860

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

http://www.wikidata.org/entity/Q34641349

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

@ast

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

@en

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

@nl

type

label

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

@ast

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

@en

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

@nl

prefLabel

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

@ast

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

@en

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

@nl

P1433

Q34641349-05012A82-10BF-4638-BD4B-554B9D747666

P1476

Q34641349-B353AC15-EEE6-41C1-A5B7-944DFFFD1B8F

P2093

Q34641349-06088C89-0E35-41B4-B1AD-6BE3B604627D

Q34641349-087249AA-0DB3-4177-A171-43F113199C08

Q34641349-0FA98B2A-FA32-4681-B4F0-BCFAEB2724FA

Q34641349-19A547D3-6390-4A91-B4B9-11A3591B70C8

Q34641349-2C275B60-D783-4F62-9F39-CC0821823BAC

Q34641349-2C55427E-D9EA-4774-AC4B-9394FDD60056

Q34641349-3510B0C0-802E-4E2F-8B06-22EF2962C9CE

Q34641349-359C31E2-5473-4F1B-A7F0-9EAA6D4827B2

Q34641349-37CFADBB-9292-4E0D-B6D3-FDD32E7AE6C3

Q34641349-3CBD0813-2611-4AB4-B666-16CA935F985E

P304

Q34641349-94A9AD6D-7D2F-4AD1-9B65-0BED3E8508C3

P31

Q34641349-1A6C49BA-0335-48C2-B28C-0C62B9780B8A

P356

Q34641349-B61F3740-878F-47DA-9292-D0622E72AEB8

P433

Q34641349-A3C46B25-43B3-4E94-B68F-73C29256BD7C

P478

Q34641349-5FB36B11-8C27-44E8-9755-A463A289463B

P50

Q34641349-EEB1C340-E670-47F3-BCDE-72D0C8ED83AD

P577

Q34641349-AD832EBA-DBC9-444F-84AC-9BF9291FFB84

P698

Q34641349-80D31256-8872-4957-82AA-2648E3DDA050

P356

JNCCN.2012.0099

P1433

Journal of the National Comprehensive Cancer Network

P1476

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines.

@en

P2093

Benjamin Paz

http://www.w3.org/2001/XMLSchema#string

Brian A Van Tine

http://www.w3.org/2001/XMLSchema#string

Christian Meyer

http://www.w3.org/2001/XMLSchema#string

Ephraim S Casper

http://www.w3.org/2001/XMLSchema#string

Ernest U Conrad

http://www.w3.org/2001/XMLSchema#string

Hema Sundar

http://www.w3.org/2001/XMLSchema#string

Herbert S Schwartz

http://www.w3.org/2001/XMLSchema#string

Jeffrey Wayne

http://www.w3.org/2001/XMLSchema#string

Joel Mayerson

http://www.w3.org/2001/XMLSchema#string

John D Pfeifer

http://www.w3.org/2001/XMLSchema#string

P304

951-960

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6004/JNCCN.2012.0099

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Margaret von Mehren

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22878820

http://www.w3.org/2001/XMLSchema#string